Transgene Biotek Shareholding

Transgene Biotek Ltd Shareholding Pattern

The Transgene Biotek Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Transgene Biotek Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Transgene Biotek Ltd (NSE: , BSE: 526139) operates in the Health technology sector and Biotechnology industry. Monitoring the Transgene Biotek Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Transgene Biotek Ltd Shareholding Pattern (Latest)

The latest Transgene Biotek Ltd shareholding for Mar 2026 is:

• Promoters: 23.64%
• FII: 0%
• DII: 0%
• Public: 76.36%
• Government: 0%

Promoter holding in Transgene Biotek Ltd remains stable, reflecting consistent long-term commitment.

Transgene Biotek Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Transgene Biotek Ltd.

• Mar 2026: 23.64%
• Dec 2025: 23.64%
• Sept 2025: 23.64%
• Jun 2025: 23.64%
• Mar 2025: 23.64%

Promoter stake remains largely stable, showing consistent ownership structure.

Transgene Biotek Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Transgene Biotek Ltd.

• Mar 2026: 0%
• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Transgene Biotek Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2026: 0%
• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%

DII holdings remain stable, reflecting steady institutional participation.

Transgene Biotek Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2026: 76.36%
• Dec 2025: 76.36%
• Sept 2025: 76.36%
• Jun 2025: 76.36%
• Mar 2025: 76.36%

Public holding remains stable with consistent retail participation.

Transgene Biotek Ltd Government Holding

Government holding in Transgene Biotek Ltd currently stands at 0%.

Transgene Biotek Ltd operates without significant government ownership.

Transgene Biotek Ltd Shareholding Analysis Summary

The Transgene Biotek Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Transgene Biotek Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Transgene Biotek Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.